ZYLOX-TONBRDG.MED.TECH.H1 (818) — Free Cash Flow Generation Index
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Free Cash Flow Generation Index of -0.10x as of December 2024. Free cash flow of €-17.26 Million represents 0% of operating cash flow (€174.08 Million). Explore 818 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ZYLOX-TONBRDG.MED.TECH.H1 Free Cash Flow Generation Index (2023–2024)
Historical FCF Generation Index trend for ZYLOX-TONBRDG.MED.TECH.H1 across 2 annual periods. For the full cash flow conversion analysis, see 818 cash generation efficiency.
Annual Free Cash Flow Generation for ZYLOX-TONBRDG.MED.TECH.H1 (2023–2024)
Year-by-year Free Cash Flow Generation Index for ZYLOX-TONBRDG.MED.TECH.H1. Check 818 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.10x | €-17.26 Million | €174.08 Million | €191.34 Million | ▲ +89.4% |
| 2023 | -0.94x | €-92.48 Million | €98.44 Million | €190.92 Million | — |